Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Infantile Hemangioma
and you are
under 84
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to assess the safety and efficacy of Timolol 0.25% and 0.5% doses.

Provided treatments

  • Drug: 0.25% Timolol Maleate Gel Forming Solution
  • Drug: 0.5% Timolol Maleate Gel Forming Solution
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02913612. The sponsor of the trial is Chiara Melloni and it is looking for 110 volunteers for the current phase.
Official trial title:
Efficacy, Safety, and Pharmacokinetics of Timolol in Infants With Infantile Hemangioma (IH)